Indofarma Tbk (Indonesia) Buy Hold or Sell Recommendation

INAF Stock  IDR 126.00  0.00  0.00%   
Assuming the 90 days trading horizon and your way above-average risk tolerance, our recommendation regarding Indofarma Tbk is 'Strong Hold'. The recommendation algorithm takes into account all of Indofarma Tbk's available fundamental, technical, and predictive indicators you will find on this site.
  
Check out Indofarma Tbk Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool.
Note, we conduct extensive research on individual companies such as Indofarma and provide practical buy, sell, or hold advice based on investors' constraints. Indofarma Tbk. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Execute Indofarma Tbk Buy or Sell Advice

The Indofarma recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Indofarma Tbk. Macroaxis does not own or have any residual interests in Indofarma Tbk or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Indofarma Tbk's advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell Indofarma TbkBuy Indofarma Tbk
Not Rated
For the selected time horizon Indofarma Tbk has a Return On Equity of -0.59, Return On Asset of -0.0451, Profit Margin of (0.1) %, Operating Margin of (0.06) %, Current Valuation of 3.17 T and Shares Outstanding of 3.1 B
Macroaxis provides investment recommendation on Indofarma Tbk to complement and cross-verify current analyst consensus on Indofarma Tbk. Our trade recommendations engine determines the entity's potential to grow exclusively from the perspective of an investor's current risk tolerance and investing horizon. To make sure Indofarma Tbk is not overpriced, please check out all Indofarma Tbk fundamentals, including its shares outstanding, price to book, and the relationship between the current valuation and shares owned by insiders .

Indofarma Tbk Trading Alerts and Improvement Suggestions

Indofarma Tbk generated a negative expected return over the last 90 days
The company reported the revenue of 2.9 T. Net Loss for the year was (37.58 B) with profit before overhead, payroll, taxes, and interest of 442.87 B.
About 88.0% of the company shares are held by company insiders

Indofarma Tbk Greeks

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Indofarma Tbk or Pharmaceuticals sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Indofarma Tbk's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Indofarma stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α
Alpha over Dow Jones
0.00
β
Beta against Dow Jones0.00
σ
Overall volatility
0.00
Ir
Information ratio 0.00

Indofarma Tbk Volatility Alert

At this time Indofarma Tbk exhibits very low volatility. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Indofarma Tbk's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Indofarma Tbk's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.

Indofarma Tbk Fundamentals Vs Peers

Comparing Indofarma Tbk's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Indofarma Tbk's direct or indirect competition across all of the common fundamentals between Indofarma Tbk and the related equities. This way, we can detect undervalued stocks with similar characteristics as Indofarma Tbk or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Indofarma Tbk's fundamental indicators could also be used in its relative valuation, which is a method of valuing Indofarma Tbk by comparing valuation metrics with those of similar companies.
    
 Better Than Average     
    
 Worse Than Average Compare Indofarma Tbk to competition
FundamentalsIndofarma TbkPeer Average
Return On Equity-0.59-0.31
Return On Asset-0.0451-0.14
Profit Margin(0.1) %(1.27) %
Operating Margin(0.06) %(5.51) %
Current Valuation3.17 T16.62 B
Shares Outstanding3.1 B571.82 M
Shares Owned By Insiders88.00 %10.09 %
Price To Book8.91 X9.51 X
Price To Sales1.25 X11.42 X
Revenue2.9 T9.43 B
Gross Profit442.87 B27.38 B
EBITDA70.22 B3.9 B
Net Income(37.58 B)570.98 M
Total Debt397.52 B5.32 B
Book Value Per Share104.92 X1.93 K
Cash Flow From Operations92.9 B971.22 M
Earnings Per Share(29.18) X3.12 X
Number Of Employees1.18 K18.84 K
Beta-0.22-0.15
Market Capitalization2.59 T19.03 B
Total Asset2.01 T29.47 B
Z Score4.68.72
Net Asset2.01 T

Indofarma Tbk Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Indofarma . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

About Indofarma Tbk Buy or Sell Advice

When is the right time to buy or sell Indofarma Tbk? Buying financial instruments such as Indofarma Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.

Use Investing Ideas to Build Portfolios

In addition to having Indofarma Tbk in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Aircraft Thematic Idea Now

Aircraft
Aircraft Theme
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Aircraft theme has 45 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Aircraft Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in Indofarma Stock

Indofarma Tbk financial ratios help investors to determine whether Indofarma Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Indofarma with respect to the benefits of owning Indofarma Tbk security.